Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Oct 09, 2020

Oxford Nanopore SARS-CoV-2 Sequencing Test Gets CE Mark

Oxford Nanopore said it is rolling out the LamPore test globally, initially in the UK, Germany, Switzerland, and the United Arab Emirates.

Oct 05, 2020

Team Shows Diagnostic Potential for Oxford Nanopore SARS-CoV-2 Assay, Calls for Improvements

Premium

A clinical evaluation of LamPore, expected to be CE marked shortly, called it promising for high-throughput testing but recommended a more streamlined workflow.

Sep 24, 2020

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

The nanopore sequencing-based test is designed to both diagnose SARS-CoV-2 infection, as well as monitor mutations that may affect efforts to combat the virus.

Sep 02, 2020

UK Invests $667M to Expand SARS-CoV-2 Testing Capacity

The funding will be used to start a new trial to assess the benefits of repeat population testing, expand existing trials, and increase PCR-based testing capacity.

Aug 03, 2020

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

Both tests can detect SARS-CoV-2 in 90 minutes and will detect viruses like influenza and respiratory syncytial virus that tend to occur in the winter.

May 28, 2020

Oxford Nanopore Technologies Raises £48.4M in Private Financing

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

Mar 05, 2020

New Sepsis Test Uses Nanopore Sequencing to Detect Pathogens From Cell-Free DNA

Premium

The method uses nanopore sequencing to analyze short cell-free DNA fragments from blood, providing results in as little as six hours.

Jan 23, 2020

Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

Premium

Mere weeks after the 2019-nCoV sequence was released, firms, agencies, and research groups have already created PCR-based tests.

Dec 16, 2019

Nanopore Sequencing Shows Promise for Rapid Diagnosis of Gut Condition in Preterm Infants

Premium

MinIon sequencing identified pathogens and antimicrobial resistance genes in the gut of preterm infants with suspected necrotizing enterocolitis.

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service. 

Pages

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.